MYCN and childhood malignant neoplasm: Akin to its structural variants in other childhood cancers, the rearrangements juxtaposed FOXR2 to a new promoter (Fig. 3a–c) and led to its overexpression as well as increased MYCN protein, which FOXR2 stabilises (Fig. 3d)27.